Mechanistic description
The debate supports carrying forward microglial priming as a partially upstream causal node rather than a pure disease-stage correlate only if a proximal endpoint changes before the late outcome. The decisive validation path is: triangulate cell-type-specific MR, scVelo trajectory direction, and longitudinal CSF cytokine Granger causality with disease-specific sensitivity analyses.
Mechanism / pathway
- TREM2
- neurodegeneration
Evidence for (1)
Analytic arms: cell-type-specific MR, scVelo trajectory, longitudinal CSF Granger causality. Exposure genes: TREM2, CX3CR1, C1QA, C1QB, C1QC. Diseases: AD, PD, ALS, MS.
Evidence against (1)
microglial activation can be both cause and response; weak eQTL instruments, cell-state drift, and disease-stage confounding could inflate upstream causal estimates
Evidence matrix
Supporting
- Analytic arms: cell-type-specific MR, scVelo trajectory, longitudinal CSF Granger causality. Exposure genes: TREM2, CX3CR1, C1QA, C1QB, C1QC. Diseases: AD, PD, ALS, MS. SDA-2026-04-28-microglial-priming-causal-nd
Contradicting
- microglial activation can be both cause and response; weak eQTL instruments, cell-state drift, and disease-stage confounding could inflate upstream causal estimates SDA-2026-04-28-microglial-priming-causal-nd
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). microglial priming as a partially upstream causal node rather than a pure disea…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-1f256c628c
@misc{scidex_hypothesis_h1f256c6,
title = {microglial priming as a partially upstream causal node rather than a pure disea…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-1f256c628c},
note = {SciDEX artifact hypothesis:h-1f256c628c}
}